Cellution Biologics buys SimpliDerm from Elutia for up to $11M
Cellution Biologics Inc. has completed its acquisition of the SimpliDerm hydrated human acellular dermal matrix business from Elutia Inc. (Nasdaq ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

